GlassScriptPhysician profile
Daniel B Chan
NPI 1275734766
$108,656.62
in general payments reported to CMS, 2019-2025
19 companies · $29K in 2025
The $29K reported for 2025 was more than what 88% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,976 · 2020: $3,395 · 2021: $93.22 · 2022: $7,387 · 2023: $19K · 2024: $45K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $88K · Food and Beverage: $2,716 · Travel and Lodging: $1,814 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $87,774.81 |
| Food and Beverage | $2,716.06 |
| Travel and Lodging | $1,814.34 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $95,118.92 | 2021-2025 | Velys, Attune, Actis |
| Synthes Gmbh | $10,744.52 | 2019-2023 | |
| Stryker Corporation | $884.54 | 2019-2025 | Mako, Insignia |
| Depuy Synthes Sales INC. | $503.96 | 2022-2025 | Actis, Na, Attune |
| Osteoremedies, LLC | $243.29 | 2024 | Osteoboost Select 10cc |
| Smith+Nephew, INC. | $169.93 | 2022-2024 | Evos |
| Arthrex, INC. | $169.39 | 2023 | Extremities & Trauma Implants Long Bone Trauma Femoral Fracture |
| Acumed LLC | $157.93 | 2023 | Ribloc |
| Illuminoss Medical, INC. | $143.93 | 2024 | |
| Trice Medical, INC. | $137.98 | 2024 | |
| Allergan, INC. | $125.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $110.35 | 2023 | A.L.P.S. |
| Bioventus LLC | $34.24 | 2023-2024 | Exogen Ultrasound Bone Healing System, Bonescalpel |
| Nalu Medical, INC. | $25.64 | 2024 | Nalu Neurostimulation System |
| Alvogen INC | $25.58 | 2025 | Teriparatide |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $18.45 | 2024 | Prolia, Evenity |
| Vertex Pharmaceuticals Incorporated | $16.69 | 2025 | |
| Janssen Pharmaceuticals, INC | $15.00 | 2020 | |
| Covidien LP | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.